These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35814402)

  • 21. Clinical features and prognostic factors of combined small cell lung cancer: development and validation of a nomogram based on the SEER database.
    Yang L; Zhou Y; Wang G; Liu D; Chen B; Pu D; Correale P; Rades D; Tomita Y; Inno A; Santarpia M; Li Y; Li W
    Transl Lung Cancer Res; 2021 Nov; 10(11):4250-4265. PubMed ID: 35004254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A clinical variable-based nomogram could predict the survival for advanced NSCLC patients receiving second-line atezolizumab.
    Shang X; Shi J; Wang X; Zhao C; Yu H; Wang H
    Cancer Med; 2021 Sep; 10(18):6218-6226. PubMed ID: 34331414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation.
    Fang S; Lai L; Zhu J; Zheng L; Xu Y; Chen W; Wu F; Wu X; Chen M; Weng Q; Ji J; Zhao Z; Tu J
    Front Mol Biosci; 2021; 8():662366. PubMed ID: 34532340
    [No Abstract]   [Full Text] [Related]  

  • 24. Preoperative diagnosis of malignant pulmonary nodules in lung cancer screening with a radiomics nomogram.
    Liu A; Wang Z; Yang Y; Wang J; Dai X; Wang L; Lu Y; Xue F
    Cancer Commun (Lond); 2020 Jan; 40(1):16-24. PubMed ID: 32125097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CT-Based Radiomics Signature: A Potential Biomarker for Predicting Postoperative Recurrence Risk in Stage II Colorectal Cancer.
    Fan S; Cui X; Liu C; Li X; Zheng L; Song Q; Qi J; Ma W; Ye Z
    Front Oncol; 2021; 11():644933. PubMed ID: 33816297
    [No Abstract]   [Full Text] [Related]  

  • 26. Development and Validation of a Radiomics Nomogram Model for Predicting Postoperative Recurrence in Patients With Esophageal Squamous Cell Cancer Who Achieved pCR After Neoadjuvant Chemoradiotherapy Followed by Surgery.
    Qiu Q; Duan J; Deng H; Han Z; Gu J; Yue NJ; Yin Y
    Front Oncol; 2020; 10():1398. PubMed ID: 32850451
    [No Abstract]   [Full Text] [Related]  

  • 27. PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs.
    Yang L; Xu P; Li M; Wang M; Peng M; Zhang Y; Wu T; Chu W; Wang K; Meng H; Zhang L
    Front Oncol; 2022; 12():894323. PubMed ID: 35800046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and Validation of a Radiomic Nomogram for Predicting the Prognosis of Kidney Renal Clear Cell Carcinoma.
    Gao R; Qin H; Lin P; Ma C; Li C; Wen R; Huang J; Wan D; Wen D; Liang Y; Huang J; Li X; Wang X; Chen G; He Y; Yang H
    Front Oncol; 2021; 11():613668. PubMed ID: 34295804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and Validation of a Nomogram Prognostic Model for Patients With Advanced Non-Small-Cell Lung Cancer.
    Wang T; Lu R; Lai S; Schiller JH; Zhou FL; Ci B; Wang S; Gao X; Yao B; Gerber DE; Johnson DH; Xiao G; Xie Y
    Cancer Inform; 2019; 18():1176935119837547. PubMed ID: 31057324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative computed tomography-guided disease-free survival prediction in gastric cancer: a multicenter radiomics study.
    Wang S; Feng C; Dong D; Li H; Zhou J; Ye Y; Liu Z; Tian J; Wang Y
    Med Phys; 2020 Oct; 47(10):4862-4871. PubMed ID: 32592224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Metabolism-Related Radiomics Signature for Predicting the Prognosis of Colorectal Cancer.
    Cai D; Duan X; Wang W; Huang ZP; Zhu Q; Zhong ME; Lv MY; Li CH; Kou WB; Wu XJ; Gao F
    Front Mol Biosci; 2020; 7():613918. PubMed ID: 33490106
    [No Abstract]   [Full Text] [Related]  

  • 32. Assessment of Clinicopathological Characteristics and Development of an Individualized Prognostic Model for Patients With Hepatoid Adenocarcinoma of the Stomach.
    Lin JX; Wang ZK; Hong QQ; Zhang P; Zhang ZZ; He L; Wang Q; Shang L; Wang LJ; Sun YF; Li ZX; Liu JJ; Ding FH; Lin ED; Fu YA; Lin SM; Xie JW; Li P; Zheng CH; Huang CM
    JAMA Netw Open; 2021 Oct; 4(10):e2128217. PubMed ID: 34609494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiomic signature of
    Jiang Y; Yuan Q; Lv W; Xi S; Huang W; Sun Z; Chen H; Zhao L; Liu W; Hu Y; Lu L; Ma J; Li T; Yu J; Wang Q; Li G
    Theranostics; 2018; 8(21):5915-5928. PubMed ID: 30613271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Nomogram To Predict The Overall Survival Of Breast Cancer Patients And Guide The Postoperative Adjuvant Chemotherapy In China.
    Wang X; Feng Z; Huang Y; Li H; Cui P; Wang D; Dai H; Song F; Zheng H; Wang P; Cao X; Gu L; Zhang J; Song F; Chen K
    Cancer Manag Res; 2019; 11():10029-10039. PubMed ID: 31819635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A radiomics nomogram based on multiparametric MRI might stratify glioblastoma patients according to survival.
    Zhang X; Lu H; Tian Q; Feng N; Yin L; Xu X; Du P; Liu Y
    Eur Radiol; 2019 Oct; 29(10):5528-5538. PubMed ID: 30847586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Prognostic Nomogram and Heat Map to Predict Survival in Stage II/III Gastric Cancer Patients After Curative Gastrectomy Followed by Adjuvant Chemotherapy.
    Shi L; Wang Z; Wang L; Jia Y; Li J; Qin Y
    Cancer Manag Res; 2022; 14():287-301. PubMed ID: 35115828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and Validation of an Immune-Based Prognostic Risk Score for Patients With Resected Non-Small Cell Lung Cancer.
    He L; Huang Y; Chen X; Huang X; Wang H; Zhang Y; Liang C; Li Z; Yan L; Liu Z
    Front Immunol; 2022; 13():835630. PubMed ID: 35401554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Adjuvant Chemotherapy on Survival of Patients With 8th Edition Stage IB Non-Small Cell Lung Cancer.
    Xu Y; Wan B; Zhu S; Zhang T; Xie J; Liu H; Zhan P; Lv T; Song Y
    Front Oncol; 2021; 11():784289. PubMed ID: 35155190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in Stage I, II resectable Non-Small Cell Lung Cancer: a retrospective multi-cohort study for outcome prediction.
    Vaidya P; Bera K; Gupta A; Wang X; Corredor G; Fu P; Beig N; Prasanna P; Patil P; Velu P; Rajiah P; Gilkeson R; Feldman M; Choi H; Velcheti V; Madabhushi A
    Lancet Digit Health; 2020 Mar; 2(3):e116-e128. PubMed ID: 32123864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival Nomogram for Stage IB Non-Small-Cell Lung Cancer Patients, Based on the SEER Database and an External Validation Cohort.
    Zuo Z; Zhang G; Song P; Yang J; Li S; Zhong Z; Tan Q; Wang L; Xue Q; Gao S; Sun N; He J
    Ann Surg Oncol; 2021 Jul; 28(7):3941-3950. PubMed ID: 33249521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.